Krones Ag Adr (KRNTY) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and a warm welcome from my side. My name is Olaf Scholz, head of group investor relations here at Crohn's. In a macroeconomic environment marked by further uncertainties, Crohn's has confirmed the financial targets for 26 and also increased order intake and profitability in the first half year 26. This was the headline of the press release this morning. And now... Thomas Ricker for the first time in his role as CEO of Crohn's and Uta Anders will give you more details about the situation at Crohn's and also explain the figures of the first half year 26. After the presentation you will have the opportunity to ask questions. I think you also know how the Q&A session works here at Crohn's. Please use the function raise your hands in Teams or send me just a short email and then I will hand over to you. Additionally, Additionally, please be reminded that this meeting will not be recorded and that it is also not allowed to record the meeting. Please also deactivate any functions of recording at Teams. So I think let's start and so I will hand over to Thomas Ricker. Thomas, the floor is yours. Thank you very much, Olaf. Dear ladies and gentlemen, It's really a pleasure for me for the first time in my new role as a CEO to present the half-year results 2026 of our company Crohn's together with my colleague Uta Anders. As I mentioned already in the Q1 call where I introduced myself, I'm very much looking forward to future direct exchange and close cooperation with the capital market and therefore with you. The current situation in the world is challenging. Thank you very much. Thank you very much. So I will just jump over this, summarize, because we will go in detail in the figures and in all these information afterwards. The highlights for the first half year in...